Isolated limb perfusion in the management of locally advanced extremity soft tissue sarcoma (Q33188139)

23 July 2017

1 reference

title

Isolated limb perfusion in the management of locally advanced extremity soft tissue sarcoma (English)

1 reference

23 July 2017

1

Alexander M Eggermont

0 references

author name string

Alexander M Eggermont

series ordinal

1

1 reference

23 July 2017

publication date

1 April 2003

1 reference

Surgical oncology clinics of North America

23 July 2017

published in

1 reference

23 July 2017

volume

12

1 reference

23 July 2017

issue

2

1 reference

23 July 2017

page(s)

469-483

1 reference

Refinement of clinicopathologic staging for localized soft tissue sarcoma of the extremity: a study of 423 adults

23 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900012-7

7 January 2021

Impact of improved local control on survival in patients with soft tissue sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900012-7

7 January 2021

High-grade soft tissue sarcomas of the extremities

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900012-7

7 January 2021

The influence of local recurrence of extremity soft tissue sarcoma on metastasis and survival

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900012-7

7 January 2021

Is local recurrence of minor importance for metastases in soft tissue sarcoma?

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900012-7

7 January 2021

Cancer statistics, 1999.

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900012-7

7 January 2021

Preoperative radiation therapy for sarcoma of soft tissue

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900012-7

7 January 2021

Is amputation necessary for sarcomas? A seven-year experience with limb salvage

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900012-7

7 January 2021

Limb salvage for skeletal and soft tissue sarcomas multidisciplinary preoperative therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900012-7

7 January 2021

Brachytherapy and function-saving resection of soft tissue sarcoma arising in the limb.

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900012-7

7 January 2021

Chemotherapy of cancer: regional perfusion utilizing an extracorporeal circuit

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900012-7

7 January 2021

Isolated limb perfusion for melanoma: effectiveness and toxicity of cisplatin compared with that of melphalan and other drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900012-7

7 January 2021

Systemic leakage during isolated limb perfusion for melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900012-7

7 January 2021

Dosimetry in isolation perfusion of the limbs by assessment of perfused tissue volume and grading of toxic tissue reactions

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900012-7

7 January 2021

Chemotherapy of Sarcomas of the Limbs by Regional Perfusion

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900012-7

7 January 2021

Regional perfusion for malignant melanoma and soft tissue sarcoma: a review

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900012-7

7 January 2021

Hyperthermic antiblastic perfusion for the treatment of soft tissue limb sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900012-7

7 January 2021

Pharmacokinetics, toxicity, and short-term results of cisplatin hyperthermic isolated limb perfusion for soft-tissue sarcoma and melanoma of the extremities

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900012-7

7 January 2021

Results of regional isolation perfusion with cytostatics in patients with soft tissue tumors of the extremities

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900012-7

7 January 2021

Phase II study on neoadjuvant hyperthermic-antiblastic perfusion with doxorubicin in patients with intermediate or high grade limb sarcomas.

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900012-7

7 January 2021

Sarcomas of the limbs. Results of adjuvant chemotherapy using isolation perfusion.

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900012-7

7 January 2021

Soft tissue sarcomas of the extremity. Multidisciplinary therapy employing hyperthermic perfusion

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900012-7

7 January 2021

Results of isolated regional perfusion in the treatment of malignant soft tissue tumors of the extremities

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900012-7

7 January 2021

An endotoxin-induced serum factor that causes necrosis of tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900012-7

7 January 2021

Tumor necrosis factor (TNF).

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900012-7

7 January 2021

Tumour necrosis factor in man: clinical and biological observations

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900012-7

7 January 2021

In vivo anti-tumour activity of recombinant human and murine TNF, alone and in combination with murine IFN-gamma, on a syngeneic murine melanoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900012-7

7 January 2021

High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900012-7

7 January 2021

Isolated limb perfusion with high-dose tumor necrosis factor-alpha in combination with interferon-gamma and melphalan for nonresectable extremity soft tissue sarcomas: a multicenter trial

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900012-7

7 January 2021

Isolated limb perfusion with tumor necrosis factor and melphalan for limb salvage in 186 patients with locally advanced soft tissue extremity sarcomas. The cumulative multicenter European experience

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900012-7

7 January 2021

Low-dose tumour necrosis factor alpha and melphalan in hyperthermic isolated limb perfusion

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900012-7

7 January 2021

Treatment of primary or relapsing limb cancer by isolation perfusion with high-dose alpha-tumor necrosis factor, gamma-interferon, and melphalan

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900012-7

7 January 2021

High dose tumor necrosis factor-alpha and melphalan administered via isolated limb perfusion for advanced limb soft tissue sarcoma results in a >90% response rate and limb preservation

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900012-7

7 January 2021

Limb salvage by neoadjuvant isolated perfusion with TNFalpha and melphalan for non-resectable soft tissue sarcoma of the extremities

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900012-7

7 January 2021

Soft tissue limb sarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900012-7

7 January 2021

Regional toxicity after isolated limb perfusion with melphalan and tumour necrosis factor- alpha versus toxicity after melphalan alone

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900012-7

7 January 2021

Absence of severe systemic toxicity after leakage-controlled isolated limb perfusion with tumor necrosis factor-alpha and melphalan

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900012-7

7 January 2021

Systemic toxicity and cytokine/acute phase protein levels in patients after isolated limb perfusion with tumor necrosis factor-alpha complicated by high leakage

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900012-7

7 January 2021

Angiographic response of locally advanced soft-tissue sarcoma following hyperthermic isolated limb perfusion with tumor necrosis factor

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900012-7

7 January 2021

31P magnetic resonance spectroscopy as predictor of clinical response in human extremity sarcomas treated by single dose TNF-alpha + melphalan isolated limb perfusion

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900012-7

7 January 2021

Isolated limb perfusion with tumour necrosis factor-alpha and melphalan with or without interferon-gamma for the treatment of in-transit melanoma metastases: a multicentre randomized phase II study.

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900012-7

7 January 2021

Hyperthermic isolated limb perfusion with tumor necrosis factor alpha, interferon gamma, and melphalan for locally advanced nonmelanoma skin tumors of the extremities: a multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900012-7

7 January 2021

Isolated limb perfusion with tumour necrosis factor-alpha and melphalan for unresectable bone sarcomas of the lower extremity

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900012-7

7 January 2021

Synergistic antitumour effect of recombinant human tumour necrosis factor alpha with melphalan in isolated limb perfusion in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900012-7

7 January 2021

Isolated limb perfusion with TNF alpha and melphalan in a rat osteosarcoma model: a new anti-tumour approach

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900012-7

7 January 2021

Synergistic effects of TNF-alpha and melphalan in an isolated limb perfusion model of rat sarcoma: a histopathological, immunohistochemical and electron microscopical study

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900012-7

7 January 2021

Tumour necrosis factor alpha increases melphalan concentration in tumour tissue after isolated limb perfusion

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900012-7

7 January 2021

TNF-alpha augments intratumoural concentrations of doxorubicin in TNF-alpha-based isolated limb perfusion in rat sarcoma models and enhances anti-tumour effects

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900012-7

7 January 2021

Assessment of the role of neutrophils on the antitumor effect of TNFalpha in an in vivo isolated limb perfusion model in sarcoma-bearing brown Norway rats

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900012-7

7 January 2021

Nitric oxide synthase inhibition results in synergistic anti-tumour activity with melphalan and tumour necrosis factor alpha-based isolated limb perfusions

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900012-7

7 January 2021

Isolated limb perfusion for local gene delivery: efficient and targeted adenovirus-mediated gene transfer into soft tissue sarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900012-7

7 January 2021

Adenovirus-mediated interleukin 3 beta gene transfer by isolated limb perfusion inhibits growth of limb sarcoma in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2803%2900012-7

7 January 2021

10.1016/S1055-3207(03)00012-7

Identifiers

DOI

1 reference

23 July 2017

1 reference